Northern Green Canada
IPS Pharma
About Black Triangle
BT3Indica HybridBlack Triangle is a rare indica hybrid strain created through crossing the infamous Triangle Kush X '88 G13 Hashplant.
Bred by 
Bodhi Seeds
Black Triangle is a relatively new strain that was created by crossing the strains Triangle Kush and '88 G13 Hashplant. Both of these parent strains are highly regarded in the cannabis community for their potency and effects.
Black Triangle typically has small to medium-sized buds that are dense and compact, with a dark green color and purple hues. The buds are covered in a thick layer of resin and have a sweet and earthy aroma, with undertones of pine and spice. The flavour is similar, with a sweet and spicy taste and a hint of earthy pine.
Black Triangle can be grown indoors or outdoors, but it requires a warm and dry climate with plenty of light and good air circulation. It has a flowering time of around 8-9 weeks and can yield moderate to high amounts of buds.
Description provided by Wikileaf.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Montu Group Pty Ltd.
We believe cannabis should be easily accessible, reliable, widely understood, and integrated into modern healthcare.
Montu is one of the leading cannabis companies in the world. Our integrated ecosystem streamlines the patient experience from beginning to end while establishing new benchmarks in cannabis care in the UK. We are dedicated to enhancing the lives of millions of people through cannabis therapy.
What we do:
- Our main goal is to eliminate barriers and create an easy-to-use, trustworthy access pathway to high-quality cannabis products within the UK market.
- We are supporting the UK medical community in better understanding the developing medical cannabis industry and its wide array of therapeutic applications.
- To stay on the cutting edge of UK market developments, such as product innovation, regulatory changes, trends, and the most recent research.
- We are operating with a long-term time horizon in the UK market and are dedicated to ensuring that patients receive the finest care possible.
Further National Health-Service Information on